Improving Health of People with Intellectual Disabilities Program

by: Iola Bonggay

The Centers for Disease Control and Prevention, otherwise referred to as CDC, is a federal government agency operating within the United States Department of Health and Human Services that is greatly responsible for protecting public health and safety through the provision of information to enhance health decisions and the promotion of health through partnerships with state health departments and other organizations.

The grants and initiatives of the CDC are all geared towards the realization of its general agency mission which is to collaborate with other agencies "to create the expertise, information, and tools that people and communities need to protect their health – through health promotion, prevention of disease, injury and disability, and preparedness for new health threats."

In keeping with this mission, the Centers for Disease Control and Prevention has constituted the Improving Health of People with Intellectual Disabilities Program in an attempt to financially support initiatives for people suffering from intellectual disabilities, thereby seeking to increase healthy behaviors and improve access to appropriate health services.

The program also intends to identify comorbid conditions and a number of poor healthy behaviors in people with intellectual disability (ID) to in order to somehow find a way to reduce or totally eliminate these behaviors and make way for better health practices.

Initially, the program is set to focus primarily on US populations but could also extend its activities internationally. By the end of the tenure of the grant, the recipient should have accomplished the following program objectives:

a) Provide health assessments, referral to services, and education to people with ID;

b) Provide health promotion training, information, and encouragement to people with ID and, when appropriate, their caregivers or service providers;

c) Train health care professionals to develop improved skills in their care of people with ID;

  (continued...)

Improving Health of People with Intellectual Disabilities Program
  Page 2

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Zambia Economic Resilience Program for Improved Food Security
The Zambia Economic Resilience Program for Improved Food Security is designed to implement innovative techniques and approaches that would hopefully enable the community's most vulnerable and poor rural families to improve food security by strengthening their economic resilience.

---

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

Clinical Trials for Organ Transplantation in Children Program
The National Insitutes of Health has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) to establish the Clinical Trials for Organ Transplantation in Children Program wherein both agencies intend to support a group of investigators in their quest of conducting clinical trials regarding pediatric solid organ transplant recipients.

---

Exploratory Clinical Trials for Small Business Grant Program
The National Institutes of Health has formed a partnership with the National Institute of Neurological Disorders and Stroke (NINDS) in order to establish the Exploratory Clinical Trials for Small Business Grant Program wherein they aim to establish a vehicle for Small Business Concerns (SBCs) in the process of submitting Small Business Technology Transfer (STTR) grant applications for exploratory clinical trials directly to the NIND

---